This resolution expresses support for designating May as National Bladder Cancer Awareness Month to promote early detection, increase research funding, and support those affected by the often-overlooked disease.
Gregory Murphy
Representative
NC-3
This resolution expresses support for designating May as National Bladder Cancer Awareness Month to highlight the serious impact of this often-overlooked cancer. It emphasizes that early detection is crucial for survival, yet awareness of symptoms and the need for research remain low. The designation aims to promote public education, support patients, and push for renewed research into better treatments and a cure.
This resolution officially throws the support of the House of Representatives behind designating May as “National Bladder Cancer Awareness Month.” This isn’t a new law that changes regulations or taxes; it’s a formal statement recognizing a serious public health issue and encouraging everyone—from researchers to the general public—to pay attention. The core message is that bladder cancer is far more common and deadly than most people realize, and we need a national push to improve awareness and research funding.
If you’re wondering why a resolution is needed, the numbers tell the story. Bladder cancer is one of the top seven most common cancers in the U.S., affecting over 800,000 families. The resolution highlights that more than 84,870 people are expected to be diagnosed this year, and over 17,420 will die. This isn't just a health crisis; it's a financial one, too, as the disease often recurs, leading to high treatment costs that drain family savings and healthcare resources.
For everyday people, the most critical takeaway here is the focus on early detection. The resolution points out that when bladder cancer is caught early, it is highly treatable. But when it’s found late, survival rates plummet. This is especially relevant for women, who are often diagnosed later than men and face worse outcomes. By designating May, the resolution aims to close this awareness gap, helping people recognize symptoms sooner, which could literally save a life.
The resolution also spotlights a major problem: there hasn't been a significant treatment breakthrough in about 30 years. It serves as a call to action for institutions like the National Institutes of Health (NIH) to keep funding high-risk research needed for a cure. This is particularly important for veterans, as the bill notes bladder cancer is one of their top four most common diagnoses, often linked to environmental exposures. This designation gives a boost to advocacy groups like the Bladder Cancer Advocacy Network, providing them with a nationally recognized platform to push for the funding and focus that patients and researchers desperately need.